Benralizumab

Benralizumab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T10497-1mg 1 mg

7 - 10 business days*

538.00€
TGM-T10497-2mg 2 mg

7 - 10 business days*

866.00€
TGM-T10497-5mg 5 mg

7 - 10 business days*

1,490.00€
TGM-T10497-10mg 10 mg

7 - 10 business days*

2,321.00€
TGM-T10497-25mg 25 mg

7 - 10 business days*

3,464.00€
 
Description: Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5... more
Product information "Benralizumab"
Description: Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Ralpha). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease. Target: Apoptosis, Interleukin, IL Receptor. References: Menzies-Gow A, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019 Sep 25,5(3). pii: 00009-2019.
Keywords: MEDI-563, BIW-8405
Supplier: TargetMol
Supplier-Nr: T10497

Properties

Conjugate: No

Database Information

CAS : 1044511-01-4| Matching products
KEGG ID : K05067 | Matching products
UniProt ID : Q01344 | Matching products
Gene ID : GeneID 3568 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Benralizumab"
Write a review
or to review a product.
Viewed